← back to search

Mei Cai

Jinan University · CN
Area of research
Management Science and Operations Research · Computational Theory and Mathematics
Research interest
Research interests include Medicine, Malignant pleural effusion, Randomized controlled trial, Methotrexate, Perfusion, and Pleural effusion.
h-index
citations
2
works
2
NIH funding
primary concept
email

Recent publications

A multicenter randomized controlled trial of intrapleural perfusion of methotrexate‐loaded tumor cell‐derived microparticles combined with systemic therapy for malignant pleural effusion
International Journal of Cancer 2025cited by 2position: middledoi
A multicenter, randomized controlled trial of intrapleural drug-loaded vesicle perfusion combined with systemic therapy for malignant pleural effusion.
Journal of Clinical Oncology 2025cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tienan Yi · Xiangyang Central Hospital2 papers (2025–2025)Hu Liu · Hebei Medical University2 papers (2025–2025)Guohua Yu · Shandong University2 papers (2025–2025)Ping Sun · Qingdao University2 papers (2025–2025)Z. Wang · Hebei Medical University2 papers (2025–2025)Hongyan Jin · Ministry of Education of the People's Republic of China2 papers (2025–2025)Sanyuan Tang · Tufts University2 papers (2025–2025)Zhimin Jiao · Jiangsu University2 papers (2025–2025)Xinyan Liu · Fudan University2 papers (2025–2025)Yan Zhang · Nantong University2 papers (2025–2025)Jiming Chen · University of Illinois Urbana-Champaign2 papers (2025–2025)Jiani Wang · Nanchang University2 papers (2025–2025)Mengxian Zhang · Tongji Hospital2 papers (2025–2025)Jingyan Zhu · Guangzhou University of Chinese Medicine2 papers (2025–2025)Sheng Hu · Anhui Medical University2 papers (2025–2025)Qingming Shi · Nanchang University2 papers (2025–2025) · 2 papers (2025–2025)Fei Ma · Academy of Medical Sciences1 papers (2025–2025)Yujing Tan · Guangdong University of Technology1 papers (2025–2025)Cheng Zeng · The First Affiliated Hospital, Sun Yat-sen University1 papers (2025–2025)